CN118159272A - 用氘化的jak抑制剂来治疗脱发病症 - Google Patents
用氘化的jak抑制剂来治疗脱发病症 Download PDFInfo
- Publication number
- CN118159272A CN118159272A CN202280068208.XA CN202280068208A CN118159272A CN 118159272 A CN118159272 A CN 118159272A CN 202280068208 A CN202280068208 A CN 202280068208A CN 118159272 A CN118159272 A CN 118159272A
- Authority
- CN
- China
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- day
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232107P | 2021-08-11 | 2021-08-11 | |
| US63/232,107 | 2021-08-11 | ||
| PCT/US2022/040115 WO2023018904A1 (en) | 2021-08-11 | 2022-08-11 | Treatment of hair loss disorders with deuterated jak inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118159272A true CN118159272A (zh) | 2024-06-07 |
Family
ID=83151848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280068208.XA Pending CN118159272A (zh) | 2021-08-11 | 2022-08-11 | 用氘化的jak抑制剂来治疗脱发病症 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12285432B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384175A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024531188A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118159272A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022328272A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228505A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023018904A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10561659B2 (en) * | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| US20230390292A1 (en) * | 2020-10-28 | 2023-12-07 | Sun Pharmaceutical Industries, Inc. | Regimens for the treatment of hair loss disorders with deuterated jak inhibitors |
| WO2023018904A1 (en) | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
| US12364699B2 (en) | 2023-10-10 | 2025-07-22 | Sun Pharmaceuticals Industries, Inc. | Method of treating hair loss disorders |
| US20260027120A1 (en) * | 2024-07-25 | 2026-01-29 | Sun Pharmaceutical Industries, Inc. | Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitors |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150197525A1 (en) * | 2012-06-15 | 2015-07-16 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
| CN109069493A (zh) * | 2016-05-04 | 2018-12-21 | 康塞特医药品有限公司 | 用氘代jak抑制剂治疗脱毛障碍 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9925962D0 (en) | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| CZ20033211A3 (cs) | 2001-05-03 | 2004-09-15 | F. Hoffmann-La Roche Ag | Farmaceutická léková forma amorfního nelfinavir mesylátu |
| WO2006039237A1 (en) | 2004-09-29 | 2006-04-13 | Cordis Corporation | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| WO2007065167A1 (en) * | 2005-12-02 | 2007-06-07 | The Johns Hopkins University | Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| HUE028588T2 (hu) | 2005-12-13 | 2016-12-28 | Incyte Holdings Corp | Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| CL2008001709A1 (es) | 2007-06-13 | 2008-11-03 | Incyte Corp | Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras. |
| WO2010083283A2 (en) | 2009-01-15 | 2010-07-22 | Incyte Corporation | Processes for preparing jak inhibitors and related intermediate compounds |
| PT2635299T (pt) | 2010-11-02 | 2019-10-14 | Univ Columbia | Métodos de tratamento de distúrbios de perda de cabelo |
| US9198911B2 (en) | 2010-11-02 | 2015-12-01 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
| DK2830662T3 (da) | 2012-03-29 | 2019-01-02 | Univ Columbia | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
| KR102242077B1 (ko) | 2012-11-15 | 2021-04-20 | 인사이트 홀딩스 코포레이션 | 룩솔리티니브의 서방성 제형 |
| MX2016010213A (es) | 2014-02-07 | 2017-04-13 | Auspex Pharmaceuticals Inc | Formulaciones farmaceuticas novedosas. |
| EP3921318A1 (en) | 2019-02-06 | 2021-12-15 | Concert Pharmaceuticals Inc. | Process for preparing enantiomerically enriched jak inhibitors |
| WO2023018904A1 (en) | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
-
2022
- 2022-08-11 WO PCT/US2022/040115 patent/WO2023018904A1/en not_active Ceased
- 2022-08-11 CA CA3228505A patent/CA3228505A1/en active Pending
- 2022-08-11 AU AU2022328272A patent/AU2022328272A1/en active Pending
- 2022-08-11 JP JP2024508384A patent/JP2024531188A/ja active Pending
- 2022-08-11 CN CN202280068208.XA patent/CN118159272A/zh active Pending
- 2022-08-11 EP EP22762213.1A patent/EP4384175A1/en active Pending
-
2023
- 2023-10-20 US US18/382,307 patent/US12285432B2/en active Active
-
2025
- 2025-03-24 US US19/088,476 patent/US20250275979A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150197525A1 (en) * | 2012-06-15 | 2015-07-16 | Concert Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
| CN109069493A (zh) * | 2016-05-04 | 2018-12-21 | 康塞特医药品有限公司 | 用氘代jak抑制剂治疗脱毛障碍 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022328272A1 (en) | 2024-02-22 |
| CA3228505A1 (en) | 2023-02-16 |
| JP2024531188A (ja) | 2024-08-29 |
| WO2023018904A1 (en) | 2023-02-16 |
| US20240058345A1 (en) | 2024-02-22 |
| US12285432B2 (en) | 2025-04-29 |
| US20250275979A1 (en) | 2025-09-04 |
| EP4384175A1 (en) | 2024-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240423986A1 (en) | Treatment of hair loss disorders with deuterated jak inhibitors | |
| US12285432B2 (en) | Treatment of hair loss disorders with deuterated JAK inhibitors | |
| US11919907B2 (en) | Deuterated JAK inhibitor and uses thereof | |
| US20250275977A1 (en) | Dosage regimens for treatment with deuterated jak inhibitors | |
| HK40112813A (en) | Treatment of hair loss disorders with deuterated jak inhibitors | |
| EA052710B1 (ru) | Лечение нарушений, характеризующихся выпадением волос, с помощью дейтерированных ингибиторов jak | |
| OA22110A (en) | Dosage Regimens For Treatment With Deuterated Jak Inhibitors. | |
| WO2026020108A1 (en) | Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitors | |
| HK40002100A (en) | Treatment of hair loss disorders with deuterated jak inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |